Danish 82c trial
WebTrial Oversight. The Danish Study to Assess the Efficacy of ICDs in Patients with Non-ischemic Systolic Heart Failure on Mortality (DANISH) was an investigator-initiated multicenter, randomized ... WebOct 2, 1997 · Background: Irradiation after mastectomy can reduce locoregional recurrences in women with breast cancer, but whether it prolongs survival remains controversial. We …
Danish 82c trial
Did you know?
WebSep 11, 2013 · The Danish group also undertook a study in high risk postmenopausal patients. Specifically, in the Danish 82c trial randomized 1460 postmenopausal patients younger than 70 years of age after total mastectomy and axillary dissection, to postmastectomy radiation therapy in addition to tamoxifen for one year or tamoxifen alone . WebThe role of postmastectomy irradiation together with systemic treatment was evaluated in high-risk patients included in the Danish Breast Cancer Cooperative Group (DBCG) protocol 82. As of June 1989, a total of 1473 pre- and menopausal patients were randomized to postmastectomy irradiation + CMF ver …
WebDec 3, 2024 · Ultimately, the DANISH trial suggests that routine ICD therapy for all patients with symptomatic ischemic cardiomyopathy with ≤35% may not result in the strong … Weband overall survival rate. The Danish 82b trial noted an improvement in overall survival at 10 years (54% versus 45%, P <.001) in premenopausal women with high-risk disease who had received CMF (cyclophos-phamide, methotrexate, fluorouracil) chemotherapy, whereas the Danish 82c trial noted a somewhat simi-lar improvement in postmenopausal women ...
WebMay 15, 1999 · Postoperative radiotherapy decreased the risk of locoregional recurrence and was associated with improved survival in high-risk postmenopausal breast-cancer … WebOct 15, 2024 · The role of RNI has primarily been defined by studies that delivered adjuvant chemotherapy including the original postmastectomy randomized trials (except Danish …
WebDec 5, 2024 · Apart from menopausal status, the DBCG 77B and 82C trials had identical selection criteria, but while 77B trial used classic CMF with oral cyclophosphamide a …
WebNov 15, 2001 · By comparison, in the Danish 82c trial, 33% of patients had ≥4 nodes involved (2). For postmastectomy patients treated on randomized trials who received chemotherapy without radiotherapy, the LRF rates for patients with 1–3 and ≥4 lymph nodes were 6–33% and 14–46%, respectively (34). fmg repair granthamWebWhat was the study population in the EORTC boost trial? stage 1-2 (T1-2, N0-1), WLE with 1 cm gross margin, ALND, 5569 pts (251 (+) margins) ... What was the chemotherapy used in the Danish 82c study? Tam: 30 daily x 1yr starting 2-4 weeks post-op. Chemo: CMF q4wk x 8 (if RT) or x 9 (no RT). greensburg then and nowWebStudy with Quizlet and memorize flashcards containing terms like Lifetime Risk of breast cancer, EIC definition, NSABP B-04 arms and more. fmg reliability engineerWebMay 15, 1999 · Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Author links open overlay panel Dr Marie Overgaard MD a, Maj-Britt Jensen MSc c, Jens Overgaard MD b, Per S Hansen MD f, ... greensburg theatre paWebJan 12, 2024 · NSABP-B06 (1976–1980) 25-Year follow-up of a randomized trial of 590, 632, and 629 patients treated with mastectomy, lumpectomy alone, or lumpectomy followed by adjuvant RT Cumulative incidence of … greensburg thrift storesWebApr 13, 2004 · As well, in the Danish 82c trial, 1 year of tamoxifen therapy was used, as opposed to the current standard of 5 years of tamoxifen therapy. In the Danish 82b trial and the British Columbia trial, CMF chemotherapy was used,5, 6 as opposed to anthracycline chemotherapy currently in common use.42 fmg repair littlehamptonWebThe Danish 82b and 82c trials were included node-negative patients who were eligible for this trial due to the presence of high-risk factors as invasion of pectoralis muscle or skin … fmg repair centre accrington